fda drug topics: development and u.s. regulation of preventative vaccines - september 27, 2022
Published 1 year ago • 3.5K plays • Length 54:56Download video MP4
Download video MP3
Similar videos
-
1:43:09
fda nanoday symposium 2022 welcome, keynote and session 1
-
44:23
fda webinar on the guidance for industry on infant formula enforcement discretion policy
-
3:44
fda cder regulatory science: the importance of partnership and consortia
-
8:27:00
176th meeting of the vaccines and related biological products advisory committee
-
1:06
what does fda do?
-
1:07:19
supplier evaluation & assessment how to meet fda qsr & iso 13485 requirements
-
5:16:51
february 10, 2022 meeting of the oncologic drugs advisory committee (odac)
-
1:31:06
the fda drug development process: glp, gmp and gcp regulations
-
9:16
fda product regulations part 4 of 7
-
6:32:04
180th meeting of vaccines and related biological products advisory committee
-
1:00
justifying an fda device classification and the regulation name and number for de novo (july 11)
-
1:00:28
writing the “indications and usage” section of labeling: fda’s new draft guidance – sep. 27, 2018
-
7:05:06
vaccines and related biological products advisory committee – 6/10/2021
-
1:17:23
fda guidance on manufacturing during covid-19 and high absenteeism
-
3:13
the impacts of fda regulations on diagnostics in oncology
-
6:15
intro to the fda office of training, education & development’s independent course delivery program
-
20:42
presentation 16 - the fda and center for drug evaluation research (cder) - anne zajicek
-
8:21:29
november 9, 2022 meeting of the pulmonary-allergy drugs advisory committee (padac)
-
20:31
fda announces quality management maturity programs
-
6:07
keynote overview – cder compliance conference
-
59:34
fda lecture: advancing the science of patient input in the regulatory settings